Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
Neonc Technologies, Inc.
Neonc Technologies, Inc.
Bristol-Myers Squibb
Pfizer
Bristol-Myers Squibb
TriSalus Life Sciences, Inc.
University of Pennsylvania
Maastricht University Medical Center
7 Hills Pharma, LLC
TCR2 Therapeutics
Incyte Corporation
Herlev Hospital
Intensity Therapeutics, Inc.
Gritstone bio, Inc.
Imperial College London
Incyte Corporation
National Cancer Center Hospital East